You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Rapid Hit Generation and Lead Elaboration for SARS-CoV-2 Therapeutics
SBC: ACCELERO BIOSTRUCTURES INC Topic: 400The novel SARS coronavirus (SARS-CoV-2) global pandemic has taken a strong foothold and it is estimated that it will infect hundreds of millions of people, with millions dying. These estimates underscore the severity of the COVID-19 disease, caused by SARS-CoV-2, yet there are currently no effective treatments that can be administered to infected individuals. Our approach centered around a proprie ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
Aerosol Delivery of Surfactant for ARDS
SBC: KAER BIOTHERAPEUTICS CORPORATION Topic: NHLBIAcute respiratory distress syndromeARDSafflicts aboutAmericans each yearThe pathology consists of rapid onset of respiratory symptoms including radiographic bilateral opacities and pulmonary edemaThe primary risk factors for the development of ARDS are pneumoniaaspirationmajor traumasepsisand inhalation injuryDespite the adoption of lung protective ventilationthe mortality rate remains aboutCommon ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
NeuroMAP System for Clinical Research
SBC: ALTEC, INC Topic: 108Motoneurons are the final neural circuits that link the brain with skeletal muscles to enable the body to move. Impairments in the ability to regulate movement currently affect over 50 million Americans suffering from various neurological or musculoskeletal conditions. Yet the deficits in motoneuron control that underlie many of these conditions are difficult to discern because current research to ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
MAGIC (R) Filter Anti-Jamming Capability for RT-1944/U Radio
SBC: ADAPTIVE DYNAMICS, INC. Topic: N131029In the Phase I Base period, Anti-Jam (A/J) enhancements exceeding 40 dB were demonstrated with operational RT-1944/U radios. During the Phase I Option period, the system will be tested against a wider range of data rates and interference conditions, and an advanced Low Rate Initial Production (LRIP) prototype currently being completed for UHF SATCOM applications will be modified to provide an init ...
SBIR Phase II 2014 Department of DefenseNavy -
Preclinical Development of Oxy200 for the Treatment of Osteoporosis
SBC: Max Biopharma, Inc. Topic: NIAABSTRACT Osteoporosis directly affectsmillion Americans and anothermillion are osteopenic and at risk for developing osteoporosisPostmenopausal osteoporosis is most commonbut osteoporosis does also frequently affect older menAt MAX BioPharmawe are developing new and improved therapies for osteoporosis that aim to rebalance both bone formation and resorption based on a dual therapy approachBisphosp ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
GigaShield USB Security for USAF SCIF
SBC: Gigavation Incorporated Topic: 1330954ABSTRACT:The objective of this effort is to perform tasks associated with development and maturation of Universal Serial Bus (USB) port security technology for securing Air Force systems from attack and data loss over USB.The proposed demonstration promises significant improvements in USB port security.Improved hardware and software will be needed to address the current Air Force IT security gap r ...
SBIR Phase II 2014 Department of DefenseAir Force -
Development of an oxygen delivery biotherapeutic for the preservation of myocardial function during pediatric cardiopulmonary bypass
SBC: OMNIOX INC Topic: NICHD1. PROJECT SUMMARY/ABSTRACT Omniox is developing a unique oxygen delivery protein, OMX, as a treatment to preserve myocardial and peripheral organ function and significantly reduce morbidity after neonatal cardiopulmonary bypass (CPB) during surgical correction of congenital heart disease (CHD). Of the ~40,000 children born annually with CHD, ~10,000 require urgent surgery to repair heart defects. ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
Multiplexed Bead-based In Vitro Pediatric Allergy Test
SBC: AMBERGEN, INC Topic: NIAIDThe CDC reports that food allergy incidence in the U Sis risingwithof children now afflicted andhaving a history of severe and potentially life threatening reactionsIn order to reduce this high incidencenew guidelines recently issued by the NIAID and also by leading allergists recommend that children betweenmonths of age be introduced to highly allergenic foods such as peanutsmilk and eggsIn addit ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
A Phase 2a Multicenter, Randomized, Vehicle-Controlled, Dose Escalating Study to Evaluate the Safety, Efficacy and Pharmacokinetics of CBT-001 Ophthalmic Solution in Pterygium Patients
SBC: CLOUDBREAK THERAPEUTICS LLC Topic: NPterygium is an ocular surface disease with abnormal fibrovascular growth on the cornea that affects aboutmillion individuals in the USLater stage disease impairs vision and the current standard of care is surgical removal of lesion tissueHoweverlesions recur in aboutof patients after surgeryBecause there is no approved drug to treat pterygiumwe propose to address this unmet medical need with a to ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
ECG Device for LQTS Screening in Newborns, Phase II
SBC: QT Medical, Inc. Topic: NHLBIDESCRIPTION provided by applicant The congenital long QT syndrome LQTS is thought to occur in in infants and cause of deaths from SIDS sudden infant death syndrome Electrocardiograms ECGs can detect LQTS before fatal cardiac events happen In our Phase I STTR project we successfully developed and tested an ECG device designed for LQTS screening in newborns This device n ...
STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health